Scanning mutagenesis of transmembrane domain 3 of the M1 muscarinic acetylcholine receptor

被引:11
作者
Hulme, EC [1 ]
Lu, ZL [1 ]
机构
[1] Natl Inst Med Res, Div Phys Biochem, London NW7 1AA, England
基金
英国惠康基金;
关键词
muscarinic; acetylcholine; G protein; mutagenesis; transmembrane;
D O I
10.1016/S0928-4257(98)80031-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Scanning mutagenesis of transmembrane domain 3 of the M1 muscarinic acetylcholine receptor has revealed a highly-differentiated a-helical structure. Lipid-facing residues are distinguished from a patch of residues which selectively stabilise the ground state of the receptor, and from a band of amino acids extending the full length of the helix, which contribute to the active agonist-receptor-aa protein complex. The most important residues are strongly conserved in the GPCR superfamily. ((C)Elsevier, Paris).
引用
收藏
页码:269 / 274
页数:6
相关论文
共 15 条
[1]   An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors [J].
Baldwin, JM ;
Schertler, GFX ;
Unger, VM .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 272 (01) :144-164
[2]   THE PROBABLE ARRANGEMENT OF THE HELICES IN G-PROTEIN-COUPLED RECEPTORS [J].
BALDWIN, JM .
EMBO JOURNAL, 1993, 12 (04) :1693-1703
[3]   SOLUBILIZATION AND CHARACTERIZATION OF GUANINE NUCLEOTIDE-SENSITIVE MUSCARINIC AGONIST BINDING-SITES FROM RAT MYOCARDIUM [J].
BERRIE, CP ;
BIRDSALL, NJM ;
HULME, EC ;
KEEN, M ;
STOCKTON, JM .
BRITISH JOURNAL OF PHARMACOLOGY, 1984, 82 (04) :853-861
[4]   OPERATIONAL MODELS OF PHARMACOLOGICAL AGONISM [J].
BLACK, JW ;
LEFF, P .
PROCEEDINGS OF THE ROYAL SOCIETY SERIES B-BIOLOGICAL SCIENCES, 1983, 220 (1219) :141-162
[5]   A HOT-SPOT OF BINDING-ENERGY IN A HORMONE-RECEPTOR INTERFACE [J].
CLACKSON, T ;
WELLS, JA .
SCIENCE, 1995, 267 (5196) :383-386
[6]   Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin [J].
Farrens, DL ;
Altenbach, C ;
Yang, K ;
Hubbell, WL ;
Khorana, HG .
SCIENCE, 1996, 274 (5288) :768-770
[7]   MAPPING THE BINDING-SITE CREVICE OF THE DOPAMINE D2 RECEPTOR BY THE SUBSTITUTED-CYSTEINE ACCESSIBILITY METHOD [J].
JAVITCH, JA ;
FU, DY ;
CHEN, JY ;
KARLIN, A .
NEURON, 1995, 14 (04) :825-831
[8]   THE FUNCTION OF A HIGHLY-CONSERVED ARGININE RESIDUE IN ACTIVATION OF THE MUSCARINIC M(1) RECEPTOR [J].
JONES, PG ;
CURTIS, CAM ;
HULME, EC .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1995, 288 (03) :251-257
[9]  
KURTENBACH E, 1990, J BIOL CHEM, V265, P13702
[10]   The role of the aspartate-arginine-tyrosine triad in the m1 muscarinic receptor: Mutations of aspartate 122 and tyrosine 124 decrease receptor expression but do not abolish signaling [J].
Lu, ZL ;
Curtis, CA ;
Jones, PG ;
Pavia, J ;
Hulme, EC .
MOLECULAR PHARMACOLOGY, 1997, 51 (02) :234-241